CNTB · Connect Biopharma Holdings Ltd
United States · RS rating 4 · As of 2026-10-14
| Price | 0.91 USD |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 10 / 3 / 14 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 22 / 17 / 24 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | +12.9% |
| Sales growth Q/Q | -100.0% |
| Distance from 52-week high | +75.4% |
| Market cap (USD) | $142.4M |